Renaud Prudent, PhD profile page

Dr. Renaud Prudent is the scientific director at Edelris, where he has implemented AS-MS screening technologies since joining in 2018. Previously, he served as chief operating officer and co-founder of Cellipse, a biotech start-up focused on oncology drug discovery. His postdoctoral research explored synthetic lethality and drug enhancers for cancer therapy. Prudent holds a PhD in chemical biology from Université Grenoble Alpes, where he specialized in screening allosteric kinase inhibitors. He has a strong background in assay development, chemical biology and translational research. At Edelris, he leads innovation in early-stage discovery platforms. Prudent has co-authored over 25 publications and patents.